Literature DB >> 18853014

[Candidemia in a tertiary hospital in northeastern Brazil].

Sylvia Lemos Hinrichsen1, Erika Falcão, Tatiana Aguiar Santos Vilella, Arnaldo Lopes Colombo, Márcio Nucci, Líbia Moura, Leandro Rêgo, Conceição Lira, Luciano Almeida.   

Abstract

We conducted a prospective, observational, laboratory-based study on candidemia to investigate the incidence of candidemia, species distribution and clinical conditions between September 2003 and March 2004 in a private tertiary hospital in Recife, northeastern Brazil. Cases of candidemia were defined as occurrences of isolation of Candida spp from blood cultures. The incidence rate was calculated per 1,000 admissions. A total of 5,532 patients were admitted to the hospital during the study period, and 1,745 blood cultures were processed. Twenty-one episodes of candidemia were observed in 18 patients. The incidence rate of candidemia was 3.9 episodes per 1,000 admissions. Non-albicans species accounted for more than 50% of the cases, and Candida parapsilosis (33%) and Candida tropicalis (24%) predominated. Eleven (61%) patients died. The incidence of candidemia was higher than that observed in a Brazilian multicenter study. Candidemia was caused predominantly by non-albicans species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18853014     DOI: 10.1590/s0037-86822008000400014

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  6 in total

1.  Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.

Authors:  Hugo Dias Hoffmann-Santos; Claudete Rodrigues Paula; Ana Caroline Akeme Yamamoto; Tomoko Tadano; Rosane C Hahn
Journal:  Mycopathologia       Date:  2013-10-11       Impact factor: 2.574

2.  Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints.

Authors:  Edileusa Rosa dos Santos; Camila F Dal Forno; Mari Glei Hernandez; Thaís Felli Kubiça; Tarcieli P Venturini; Francieli Chassot; Janio M Santurio; Sydney Hartz Alves
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Nov-Dec       Impact factor: 1.846

3.  Antifungal Drug Susceptibility of Candida Species Isolated from HIV-Positive Patients Recruited at a Public Hospital in São Luís, Maranhão, Brazil.

Authors:  Ana L G Terças; Sirlei G Marques; Eduardo B Moffa; Márcia B Alves; Conceição M P S de Azevedo; Walter L Siqueira; Cristina A Monteiro
Journal:  Front Microbiol       Date:  2017-03-02       Impact factor: 5.640

Review 4.  Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis.

Authors:  Liliana Scorzoni; Ana C A de Paula E Silva; Caroline M Marcos; Patrícia A Assato; Wanessa C M A de Melo; Haroldo C de Oliveira; Caroline B Costa-Orlandi; Maria J S Mendes-Giannini; Ana M Fusco-Almeida
Journal:  Front Microbiol       Date:  2017-01-23       Impact factor: 5.640

5.  Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of São Paulo State, Brazil.

Authors:  D K B Rodrigues; L X Bonfietti; R A Garcia; M R Araujo; J S Rodrigues; V M F Gimenes; M S C Melhem
Journal:  Braz J Med Biol Res       Date:  2021-06-14       Impact factor: 2.590

6.  Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit.

Authors:  Henrique Marconi Sampaio Pinhati; Luiz Augusto Casulari; Ana Carolina Remondi Souza; Ricardo Andreotti Siqueira; Camila Maria Gomes Damasceno; Arnaldo Lopes Colombo
Journal:  BMC Infect Dis       Date:  2016-08-20       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.